Pharming (PHAR) Gains from Investment Securities (2019 - 2023)
Historic Gains from Investment Securities for Pharming (PHAR) over the last 4 years, with Q2 2023 value amounting to -$442000.0.
- Pharming's Gains from Investment Securities changed N/A to -$442000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of -$2658.0 for FY2020, which is 9995.35% up from last year.
- Per Pharming's latest filing, its Gains from Investment Securities stood at -$442000.0 for Q2 2023.
- Pharming's 5-year Gains from Investment Securities high stood at $3.4 million for Q3 2022, and its period low was -$5.6 million during Q4 2019.
- Over the past 4 years, Pharming's median Gains from Investment Securities value was -$442000.0 (recorded in 2023), while the average stood at -$1.1 million.
- Data for Pharming's Gains from Investment Securities shows a peak YoY increase of 9995.09% (in 2020) and a maximum YoY decrease of 9995.09% (in 2020) over the last 5 years.
- Pharming's Gains from Investment Securities (Quarter) stood at -$5.6 million in 2019, then surged by 99.95% to -$2773.3 in 2020, then soared by 123313.02% to $3.4 million in 2022, then plummeted by 112.94% to -$442000.0 in 2023.
- Its Gains from Investment Securities was -$442000.0 in Q2 2023, compared to $3.4 million in Q3 2022 and -$2773.3 in Q4 2020.